Medicare Enrolled
Dr. Robert Havard, MD
Hematology · Visalia, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Havard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Havard?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Havard
Dr. Robert Havard is a hematology specialist in Visalia, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Havard performed 143,212 Medicare services across 3,442 unique beneficiaries.
Between the years covered by Open Payments, Dr. Havard received a total of $30,772 from 99 pharmaceutical and/or device companies across 1694 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Havard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in CA
$30,772 industry payments
Medicare Practice Summary
Medicare Utilization ↗143,212
Medicare services
Top 1% in CA for hematology
3,442
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,161 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, heparin sodium, (heparin lock flush), per 10 units | 20,040 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 19,400 | $43 | $88 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
17,700 | $0 | $6 |
| Paclitaxel chemotherapy injection | 16,538 | $0 | $6 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
16,500 | $1 | $2 |
| Nivolumab injection (Opdivo) | 9,000 | $24 | $48 |
| Denosumab injection (Prolia/Xgeva) | 7,560 | $18 | $38 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
7,020 | $24 | $73 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,939 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
5,120 | $6 | $22 |
| Injection, granisetron hydrochloride, 100 mcg | 3,140 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,680 | $1 | $34 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,440 | $8 | $29 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,191 | $98 | $165 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,479 | $8 | $11 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
831 | $13 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
796 | $111 | $242 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
661 | $2 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
648 | $11 | $38 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
401 | $24 | $55 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
318 | $1 | $4 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
267 | $67 | $115 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
248 | $1 | $5 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
241 | $24 | $77 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
220 | $55 | $117 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
212 | $6 | $165 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
186 | $52 | $110 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
138 | $2 | $5 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
122 | $61 | $123 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
122 | $85 | $168 |
| Injection, triptorelin pamoate, 3.75 mg | 118 | $297 | $835 |
| New patient office visit, complex (60-74 min) | 113 | $173 | $313 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
108 | $27 | $86 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
90 | $10 | $26 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
83 | $97 | $163 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
82 | $72 | $158 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
81 | $28 | $69 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
81 | $1 | $7 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
66 | $21 | $43 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
64 | $1 | $2 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 43 | $340 | $831 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
38 | $29 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $114 | $286 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $141 | $305 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $128 | $227 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
11 | $150 | $293 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.9% high complexity
82.1% medium
5.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$30,772
Total received (2018-2024)
Avg $4,396/year across 7 years
Top 31% in CA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,694
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,163 (94.8%)
Other
Charitable contributions, space rental, and other categories
$1,468 (4.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$141 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,831
2023
$6,261
2022
$6,332
2021
$4,547
2020
$3,100
2019
$3,344
2018
$3,357
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,468
GlaxoSmithKline, LLC.
$348
Janssen Biotech, Inc.
$174
AstraZeneca Pharmaceuticals LP
$165
Merck Sharp & Dohme LLC
$145
Celgene Corporation
$134
Daiichi Sankyo Inc.
$121
GENZYME CORPORATION
$100
Eisai Inc.
$97
Exelixis Inc.
$89
SOBI, INC
$76
PFIZER INC.
$73
Genentech USA, Inc.
$71
ARRAY BIOPHARMA INC
$64
ACCORD HEALTHCARE, INC.
$63
Ipsen Biopharmaceuticals, Inc
$63
Apellis Pharmaceuticals, Inc.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$46
E.R. Squibb & Sons, L.L.C.
$45
PUMA BIOTECHNOLOGY, INC.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
JAZZ PHARMACEUTICALS INC.
$37
Lilly USA, LLC
$36
ImmunoGen, Inc.
$29
Incyte Corporation
$26
Medtronic, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$23
Azurity Pharmaceuticals, Inc.
$21
ADC Therapeutics America, Inc.
$20
Aveo Pharmaceuticals, Inc.
$19
Mirati Therapeutics, Inc.
$18
Fennec Pharmaceuticals, Inc.
$18
Coherus Biosciences Inc.
$18
Acrotech Biopharma Inc.
$17
Deciphera Pharmaceuticals Inc.
$16
EMD Serono, Inc.
$16
Top 3 companies account for 51.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,871
AstraZeneca Pharmaceuticals LP
$2,454
E.R. Squibb & Sons, L.L.C.
$2,088
Janssen Biotech, Inc.
$1,783
Amgen Inc.
$1,772
GlaxoSmithKline, LLC.
$1,495
Genentech USA, Inc.
$1,251
Celgene Corporation
$1,108
Exelixis Inc.
$1,058
PFIZER INC.
$899
Daiichi Sankyo Inc.
$887
Lilly USA, LLC
$792
GENZYME CORPORATION
$714
Merck Sharp & Dohme LLC
$664
Eisai Inc.
$572
EISAI INC.
$495
Bayer HealthCare Pharmaceuticals Inc.
$461
Seagen Inc.
$453
Incyte Corporation
$421
Gilead Sciences, Inc.
$421
Merck Sharp & Dohme Corporation
$396
Takeda Pharmaceuticals U.S.A., Inc.
$337
Regeneron Healthcare Solutions, Inc.
$334
Alexion Pharmaceuticals, Inc.
$314
Secura Bio, Inc.
$307
Seattle Genetics, Inc.
$277
SOBI, INC
$272
MorphoSys, US Inc.
$269
EMD Serono, Inc.
$266
Ipsen Biopharmaceuticals, Inc
$252
Astellas Pharma US Inc
$251
Puma Biotechnology, Inc.
$237
AVEO Pharmaceuticals, Inc.
$209
Pharmacyclics LLC, An AbbVie Company
$189
ARRAY BIOPHARMA INC
$188
Sobi, Inc
$184
Blueprint Medicines Corporation
$168
Dova Pharmaceuticals
$163
Stemline Therapeutics Inc.
$153
Kite Pharma, Inc.
$146
Clovis Oncology, Inc.
$144
Bayer Healthcare Pharmaceuticals Inc.
$141
Karyopharm Therapeutics Inc.
$141
Apellis Pharmaceuticals, Inc.
$139
TESARO, Inc.
$129
INSYS Therapeutics Inc
$125
Coherus Biosciences Inc.
$122
SERVIER PHARMACEUTICALS LLC
$114
Kyowa Kirin, Inc.
$106
Rigel Pharmaceuticals, Inc.
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
Octapharma USA, Inc.
$94
TerSera Therapeutics LLC
$91
AMAG Pharmaceuticals, Inc.
$82
ADC Therapeutics America, Inc.
$76
Mirati Therapeutics, Inc.
$74
JAZZ PHARMACEUTICALS INC.
$74
PUMA BIOTECHNOLOGY, INC.
$66
ACCORD HEALTHCARE, INC.
$63
Teva Pharmaceuticals USA, Inc.
$63
ABBVIE INC.
$62
MEDIVATION FIELD SOLUTIONS LLC
$61
Aveo Pharmaceuticals, Inc.
$59
Pharmacyclics LLC, an AbbVie Company
$57
AbbVie Inc.
$53
Pharmacosmos Therapeutics Inc.
$53
BeiGene USA, Inc.
$50
Taiho Oncology, Inc.
$44
Myriad Genetic Laboratories, Inc.
$44
Acrotech Biopharma LLC
$43
G1 Therapeutics, Inc.
$39
Medtronic, Inc.
$37
Dendreon Pharmaceuticals LLC
$37
Deciphera Pharmaceuticals Inc.
$35
MAYNE PHARMA INC.
$34
TAIHO ONCOLOGY, INC.
$33
Myovant Sciences Inc.
$30
ImmunoGen, Inc.
$29
CTI BioPharma Corp.
$27
Janssen Pharmaceuticals, Inc
$26
Epizyme, Inc.,
$24
Azurity Pharmaceuticals, Inc.
$21
Acerta Pharma LLC
$21
Fresenius Kabi USA, LLC
$18
EUSA Pharma (US) LLC
$18
RECORDATI_RARE_DISEASES_INC.
$18
Fennec Pharmaceuticals, Inc.
$18
Heron Therapeutics, Inc.
$17
Acrotech Biopharma Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Sirtex Medical Inc
$16
Acceleron Pharma, Inc.
$15
Cumberland Pharmaceuticals, Inc.
$13
Aurobindo Pharma USA, Inc.
$13
SANOFI-AVENTIS U.S. LLC
$11
Lexicon Pharmaceuticals, Inc.
$11
Mylan Institutional Inc.
$11
Agios Pharmaceuticals, Inc.
$11
SECURA BIO, INC.
$10
Top 3 companies account for 24.1% of all-time payments
Associated products mentioned in payments ›
ABIRATERONE ACETATE TABLETS · ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · COPIKTRA · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Erleada · FARESTON · FARYDAK · FASLODEX · FERAHEME · FOLOTYN · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · Fulphila · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stimufend · Stivarga · Sustol · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TRIPTODUR · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YERVOY · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematologists within 10 mi
2
Per 100K population
0.4
County median income
$69,489
Nearest hospital
KAWEAH HEALTH MEDICAL CENTER
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Havard is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Havard experienced with injection, heparin sodium, (heparin lock flush), per 10 units?
Based on Medicare claims data, Dr. Havard performed 20,040 injection, heparin sodium, (heparin lock flush), per 10 units services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Havard receive payments from pharmaceutical companies?
Yes. Dr. Havard received a total of $30,772 from 99 companies across 1,694 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Havard's costs compare to other hematologists in Visalia?
Dr. Havard's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Havard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Visalia
Browse hematologists in Visalia ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in CA
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in CA
Which CA hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology